Physician profile

Andrew Yin

Cardiovascular Disease · Naples, FL

NPI 1417162199

$8,833.68

in general payments reported to CMS, 2019-2025

18 companies · $1,436 in 2025

The $1,436 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,472.22
Travel and Lodging$665.66

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $2,691.65 2019-2025 Aveir, Perclose Prostyle, Gallant
Boston Scientific Corporation $2,477.77 2019-2025 General - Therapies, Farapulse, Watchman Flx
Medical Device Business Services, INC. $613.43 2021
Cvrx, INC. $489.54 2020-2025 Barostim Neo System
Biosense Webster, INC. $486.07 2019-2025 Carto 3, Qdot Micro Catheter
Atricure, INC. $374.04 2022-2025 Epi-Sense Guided Coagulation System With Visitrax
Janssen Pharmaceuticals, INC $339.42 2019-2021
Cardiofocus, INC. $337.24 2020
Kestra Medical Technology Services, INC. $271.46 2023 Assure Wcd
Impulse Dynamics (USA) INC. $187.80 2021-2024 Optimizer
Ge Healthcare $184.38 2021
E.R. Squibb & Sons, L.L.C. $140.31 2021-2022
Alnylam Pharmaceuticals INC. $97.47 2019
Novartis Pharmaceuticals Corporation $42.02 2020-2022
Philips North America LLC $34.86 2024 (Cm9) Amb Mon & Diag Und
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Medtronic, INC. $24.23 2023 Micra
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $21.19 2022-2024 Lifevest
Pfizer INC. $20.80 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Andrew Yin

$8,833.68

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,436 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/199920/andrew-yin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.